An ex-FDA employee has revealed what he claims is the most harmful breakfast cereal on the U.S. market.

Bladder cancer is a relatively small indication for Trodelvy, representing less than 10% of the drug’s sales, Gilead’s CFO ...

As Ghana makes significant strides in vaccine production, the Food and Drugs Authority (FDA) has confirmed its readiness and capacity to test these vaccines, ensuring their safety for public use.

Tobacco consumption among U.S. adolescents has seen significant decline in 25 years as per new federal data published on ...

Gilead in 2021 won the FDA accelerated nod for Trodelvy in metastatic urothelial cancer, but continued approval was contingent on the outcome of a confirmatory study. The company in late May said that ...

You may not be able to count on it for as long as you'd anticipate, say experts who call the risk high. Here's who's affected ...

Lumryz is an extended-release formulation of sodium oxybate, a central nervous system (CNS) depressant. Its therapeutic effects are believed to be mediated through GABA B actions at noradrenergic and ...

A study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential ...

Is AI just hype or a game-changer? Delve into AI's contribution to oncology, from diagnostics to drug discovery and ...

SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.

Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for previously treated patients with a type ...